BioSpace News Archive

T2 Biosystems, Inc. announced that on May 5, 2022 it received a letter from The Nasdaq Stock Market informing the Company that its shares of common stock have failed to comply with the $1.00 minimum bid price required for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450, and, as a result, the Company’s shares are subject to delisting.

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, reported financial results for the three months ended March 31, 2022.

Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported first quarter 2022 financial results and corporate updates.

ChemoCentryx, Inc., announced financial results for the first quarter ended March 31, 2022 and provided an overview of recent corporate highlights.

Organogenesis Holdings Inc. announced the appointments of Michele Korfin and Gilberto Quintero, Ph.D. to the Company’s Board of Directors, effective May 3, 2022.

TOMI Environmental Solutions, Inc. today announced its financial results for the first quarter of 2022.

Natus Medical Incorporated announced financial results for the three months ended March 31, 2022.

electroCore, Inc. announced first quarter 2022 financial results and provided an operational update.

Applied Molecular Transport Inc. will participate in a fireside chat during the BofA Securities 2022 Healthcare Conference in Las Vegas on Tuesday, May 10, 2022 at 2:20 p.m. ET.

PROCEPT® BioRobotics Corporation, a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, reported unaudited financial results for the quarter ended March 31, 2022.